Netherlands: Rapid Response 2017

*The deadline for submitting applications to the Netherlands: Rapid Response 2017 program has now passed*

The prevalence of neurodegenerative diseases of aging is high and growing rapidly. The Netherlands: Rapid Response 2017 program was created to jumpstart the development of safe and effective treatments for these diseases. The program provides seed funding for novel, high-risk, high-reward translational research projects in the Netherlands.  Proposed projects may relate to any disease; however, the basis for selection will be on the potential impact of the project on neurodegenerative diseases of aging.

NEW FOR 2017

  • Projects can request up to €200,000 over up to 2 years.
  • Applicants can submit any number of LOIs.
  • Project can include small animal models (up to and including rodents).

Funding and Eligibility

Projects can request up to €200,000 over up to 2 years for novel, high-risk, high-reward translational research that accelerates the development of therapeutics for neurodegenerative diseases of aging.

The Principal Applicant must be either a researcher at or above the level of Universitair Docent (or equivalent) or a researcher at or above the level of Post-doctoral Fellow with an Administrative Supervisor at a Public Benefit Organisation in the Netherlands.

Projects must meet two conditions to be eligible:

  1. Be translational research that helps accelerate the development of therapeutics for neurodegenerative diseases of aging.
  2. Be the development of a therapeutic (e.g., small molecules, biologics, brain stimulation) and/or tool (e.g., imaging, techniques/reagents, biomarkers).

Among other things, this call excludes:

  • Basic research (also known as fundamental research).
  • Projects focused on patient care and management.
  • Projects focused on complementary approaches (e.g., exercise, diet, acupuncture, nutritional supplements, and enriched environments).
  • Research performed with animals larger than rodents.

Important Dates

Program Information Session: Tuesday, October 4th, 2016 at 16:00 CEST (further details below)

Letter of Intent (LOI) Deadline: Tuesday, October 25th, 2016 at 16:00 CEST

Proposal Invitations: December 2016

Proposal Deadline: Thursday, February 9th, 2017 at 16:00 CET

Anticipated Award Notification: March 2017

*Dates may change


Application Process

There are two stages to the application process:  Letter of Intent (LOI) and Proposal stages. An application requires the submission of a Letter of Intent which will be reviewed by our Scientific Review Committee. Applicants with high potential projects will be invited to submit a Proposal; instructions will be forwarded along with the invitation in December, 2016.

Please refer to our Program Details for more information on this opportunity.

Request for Applications (RFA)

Program Details

Letter of Intent


Program Information Session

The online Program Information Session will be held on Tuesday, October 4th, 2016 at 16:00 CEST and will provide further details on the program and application process, with an opportunity to ask questions.

Please register to attend the information session here.


Important Institute Definitions

Please refer to our Funding Overview page for a complete list of:

  • Neurodegenerative diseases of aging as defined by the Institute.
  • Other definitions at the Institute, including an updated definition of Tools.

The Institute welcomes inquiries about this request for applications or any of our other funding opportunities. We would be pleased to hear from you at either neuro@weston.ca or +1 416-935-4056.

Information on the previous 2016 iteration of the Netherlands: Rapid Response program can be found here.